Trial intelligence / Profile preview

TMP/SMX as PCP Prophylaxis in Connective Tissue Diseases

NCT01747278Phase 3Unknown

Sponsor
Peking Union Medical College Hospital
Start
Aug 2012
Primary completion
Jun 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of trimethoprim + sulfamethoxazole in Pneumocystis pneumonia (PCP), sponsored by Peking Union Medical College Hospital. Status: unknown.

02

Drugs

trimethoprim + sulfamethoxazole
03

Conditions

Pneumocystis pneumonia (PCP)

Beyond the preview

Go deeper on NCT01747278.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01747278.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call